Literature DB >> 22065762

Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding.

Maika S Deffieu1, Suzanne R Pfeffer.   

Abstract

Niemann-Pick type C1 (NPC1) protein is needed for cellular utilization of low-density lipoprotein-derived cholesterol that has been delivered to lysosomes. The protein has 13 transmembrane domains, three large lumenal domains, and a cytoplasmic tail. NPC1's lumenally oriented, N-terminal domain binds cholesterol and has been proposed to receive cholesterol from NPC2 protein as part of the process by which cholesterol is exported from lysosomes into the cytosol. Using surface plasmon resonance and affinity chromatography, we show here that the second lumenal domain of NPC1 binds directly to NPC2 protein. For these experiments, a soluble NPC1 lumenal domain 2 was engineered by replacing adjacent transmembrane domains with antiparallel coiled-coil sequences. Interaction of NPC2 with NPC1 lumenal domain 2 is only detected at acidic pH, conditions that are optimal for cholesterol binding to NPC2 and transfer to NPC1; the pH is also appropriate for the acidic environment where binding would take place. Binding to NPC1 domain 2 requires the presence of cholesterol on NPC2 protein, a finding that supports directional transfer of cholesterol from NPC2 onto NPC1's N-terminal domain. Finally, human disease-causing mutations in NPC1 domain 2 decrease NPC2 binding, suggesting that NPC2 binding is necessary for NPC1 function in humans. These data support a model in which NPC1 domain 2 holds NPC2 in position to facilitate directional cholesterol transfer from NPC2 onto NPC1 protein for export from lysosomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22065762      PMCID: PMC3223457          DOI: 10.1073/pnas.1110439108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Design and characterization of a heterodimeric coiled coil that forms exclusively with an antiparallel relative helix orientation.

Authors:  D L McClain; H L Woods; M G Oakley
Journal:  J Am Chem Soc       Date:  2001-04-04       Impact factor: 15.419

2.  Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.

Authors:  G Millat; C Marçais; C Tomasetto; K Chikh; A H Fensom; K Harzer; D A Wenger; K Ohno; M T Vanier
Journal:  Am J Hum Genet       Date:  2001-05-01       Impact factor: 11.025

Review 3.  Niemann-Pick C research from mouse to gene.

Authors:  Peter G Pentchev
Journal:  Biochim Biophys Acta       Date:  2004-10-11

4.  Topological analysis of Niemann-Pick C1 protein reveals that the membrane orientation of the putative sterol-sensing domain is identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and sterol regulatory element binding protein cleavage-activating protein.

Authors:  J P Davies; Y A Ioannou
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

Review 5.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

Review 6.  Sorting things out through endoplasmic reticulum quality control.

Authors:  Taku Tamura; Johan C Sunryd; Daniel N Hebert
Journal:  Mol Membr Biol       Date:  2010-06-17       Impact factor: 2.857

Review 7.  Niemann-Pick disease type C.

Authors:  M T Vanier; G Millat
Journal:  Clin Genet       Date:  2003-10       Impact factor: 4.438

8.  Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Sandy M Price; Lucie Verot; Michael M Shen; G Stephen Tint; Marie T Vanier; Steven U Walkley; Peter Lobel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

9.  Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1.

Authors:  Walter D Park; John F O'Brien; Patrick A Lundquist; Daniel L Kraft; Cate Walsh Vockley; Pamela S Karnes; Marc C Patterson; Karen Snow
Journal:  Hum Mutat       Date:  2003-10       Impact factor: 4.878

10.  Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease.

Authors:  Natalia Friedland; Heng-Ling Liou; Peter Lobel; Ann M Stock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

View more
  80 in total

Review 1.  The potential of histone deacetylase inhibitors in Niemann - Pick type C disease.

Authors:  Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  FEBS J       Date:  2013-09-23       Impact factor: 5.542

2.  Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.

Authors:  Kanagaraj Subramanian; Darren M Hutt; Samantha M Scott; Vijay Gupta; Shu Mao; William E Balch
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

3.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

4.  Scientific side trips: six excursions from the beaten path.

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

5.  Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream.

Authors:  Anna M Taylor; Bing Liu; Yelenis Mari; Benny Liu; Joyce J Repa
Journal:  J Lipid Res       Date:  2012-08-14       Impact factor: 5.922

6.  Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.

Authors:  Nina H Pipalia; Kanagaraj Subramanian; Shu Mao; Harold Ralph; Darren M Hutt; Samantha M Scott; William E Balch; Frederick R Maxfield
Journal:  J Lipid Res       Date:  2017-02-13       Impact factor: 5.922

7.  δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders.

Authors:  Miao Xu; Ke Liu; Manju Swaroop; Forbes D Porter; Rohini Sidhu; Sally Firnkes; Sally Finkes; Daniel S Ory; Juan J Marugan; Jingbo Xiao; Noel Southall; William J Pavan; Cristin Davidson; Steven U Walkley; Alan T Remaley; Ulrich Baxa; Wei Sun; John C McKew; Christopher P Austin; Wei Zheng
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

Review 8.  Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.

Authors:  Paul Helquist; Frederick R Maxfield; Norbert L Wiech; Olaf Wiest
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

9.  Distinct Cation Gradients Power Cholesterol Transport at Different Key Points in the Hedgehog Signaling Pathway.

Authors:  Kostadin Petrov; Bradley M Wierbowski; Jingjing Liu; Adrian Salic
Journal:  Dev Cell       Date:  2020-08-28       Impact factor: 12.270

10.  Glycosylation inhibition reduces cholesterol accumulation in NPC1 protein-deficient cells.

Authors:  Jian Li; Maika S Deffieu; Peter L Lee; Piyali Saha; Suzanne R Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.